Morbo di Parkinson

Agnoli A Baldassarre M Ruggieri S : II problema del parkinsonismo arteriosclerotico. In: Caraceni T Nappi S , (eds): Morbo di Parkinson e malattie extrapiramidali. Ed Mediche Italiane. Pavia 1986: 131–143.

Bannister R Mathias C : Testing autonomic reflexes. In: Bannister R , (ed): Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford 1988: 289–307.

Barbeau A : The clinical physiology of side effects in long-term L-dopa therapy. Adv Neurol, 5: 347–365, 1974.

Baronti F Conant KE : Opioid peptides in Parkinson's disease: Effects of dopamine repletion. Brain Res, 560: 92–96, 1990.

Brooks DJ Salmon EP : The integrity of the dopaminergic system in multiple system atrophy and pure autonomic failure studied with PET. J Neurol Neurosurg Psychiat, 53: 383–389, 1989.

Capria A Attanasio A : Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease. Clin Neuropharmacol, 4: 331–338, 1989.

Fahn S : On-off phenomenon with levodopa therapy in Parkinsonism. Neurology, 24: 431–441, 1980.

Hardie R Lees A Stern GM : On-off fluctuations in Parkinson's disease. Trends Neurol Sci, 4: 487–506, 1984.

Hornykiewicz O : Compensatory biochemical changes at the striatal dopamine synapse in Parkinson's disease limitations of L-dopa therapy. Adv Neurol, 24: 275–281, 1979.

Kirby R Fowler C : Urethro-vescical disfunction in progressive autonomic failure with multiple system atrophy. J Neurol Neurosurgery Psychiat, 49: 554–562, 1986.

Lee T Seeman P : Receptor basis dor dopaminergic supersensitivity in Parkinson's disease. Nature, 273: 59–61, 1978.

Leenders KL Palmer AJ : Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurosurg Psychiat, 49: 853–860, 1986.

Lesser RP Fahn S : Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology, 29: 1253–1260, 1979.

Marsden CD Parkes JP : On-off effects in patients with Parkinson's disease on chronic levedopa therapy. Lancet, I: 292–296, 1976.

Marsden CD Jenner P : L- dopa's action in Parkinson's disease. Trends Neurol Sci, 4: 148–150, 1981.

Melamed E Hefti F Wurtman RJ : Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol, 8: 558–563, 1980.

Melamed E Hefti F : Aromatic L-amino acid decarboxylase in rat corpus striatum: Implications for action L-dopa in Parkinsonism. Neurology, 31: 651–655, 1981.

Pastakia B Polinski R : Multiple system atrophy (Shy-Drager syndrome): NR imaging. Radiology, 159: 493–498, 1986.

Prasher D Bannister R : Brain stem auditory evoked potentials in patients with multiple system atrophy with progressive autonomic failure (Shy-Drager syndrome). J Neurol Neurosurg Psychiat, 49: 278–289, 1986.

Quinn N : Multiple system atrophy - the nature of the beast. J Neurol Nsurosurg Psychiat (suppl)78–89, 1989.

Ruggieri S Stocchi F Agnoli A : Lisuride infusion pump for Parkinson's disease. Lancet, II: 348–349, 1986.

Ruggieri S Stocchi F : Side-effects of subcutaneous apomorphine in Parkinson's disease. Lancet, I: 566, 1989.

Rutledge JN Hilal SK : Studies of movement disorders and brain iron bY MR. Am J Neuroradiol, 8: 397–411, 1987.

Schwartz J Tatsch K : 123 iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with no de novo parkinsonisn. Neurology, 3: 556–561, 1992.

Stocchi F Carbone A : Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease. 10th International Symposium on Parkinson's Disease Abstracts (101), Tokyo, October 27–30, 1991.